← Analysis page  ·  Pieter Slegers hub  ·  Research hub

Actionable insights — Buying The Next Berkshire Hathaway

Running a shortlist-to-purchase pipeline, underwriting a compounder by the length of its record rather than by a multiple, and reading a limit price as a statement of intent.
2026-AUG-16 · Compounding Quality (Substack) · Pieter Slegers / Team Compounding Quality · read ↗ · full analysis · transcript
How to read this page: a short transaction issue, so the methods are about execution and evidentiary standards rather than analysis. The last insight is a criticism — this purchase is made to a lower standard of proof than the archive applies to everything it already owns, and noticing that is itself the transferable skill. Written post, so no timestamps.

1. Buy only from a published shortlist, and let the lag between listing and purchase be visible

The repeatable method
  1. Maintain a small, ranked shortlist of names you would own, separate from what you already own.
  2. Refresh it on a fixed cadence, and require any new purchase to have been on it first.
  3. When you buy, say when the name was listed and at what rank. The lag is the evidence that the decision was made in advance rather than reactively.
  4. Review the names that were listed and never bought — that residue is where the discipline actually shows.
Here: FFH.TO was Best Buy #2 on 19 July and is bought on 16 August — four weeks. SPGI was #1 on the same list and was bought seven days later. The July issue's hint, "it's very likely that we might buy 2 of the 3 companies from our top 3," has now been half-delivered on the record.
Watch for

2. State the length of record at which you will treat a track record as skill

The repeatable method
  1. Decide, in advance and in general, how long a record has to be before you will underwrite it as skill rather than luck.
  2. Apply it symmetrically — to managers you like and to those you do not.
  3. Check that the record was produced by the same person, the same strategy and the same capital base you are buying into now.
  4. Separate the record from the forecast: a long record supports the claim that the process works, not the claim that a specific growth rate will be achieved.
Here: "The stock returned 19.5% (!) per year since 1985… Strong returns over a few years can be luck. But outperforming the market for more than 40 years takes extraordinary skill." Forty years, one man, the same insurance-float structure throughout — the cleanest form of this test available.
Watch for

3. When underwriting by analogy, name the specific mechanism that transfers

The repeatable method
  1. Identify the structural mechanism the comparison rests on — here, insurance float invested in securities at low cost.
  2. Verify it operates the same way in the candidate: is the underwriting profitable, so the float is genuinely free?
  3. Name the differences explicitly — size, geography, capital structure, regulatory regime, succession.
  4. Reject the analogy if what transfers is only the biography. "Run by a great investor" is not a mechanism.
  5. State what the analogy predicts, so it can be checked later.
Here: the mechanism is stated — "just like Berkshire Hathaway they use their float to invest in stocks" — and so is Watsa's four-part synthesis: Buffett on float, Graham on value, Templeton on contrarian global investing, Singleton on buying back your own shares. The size difference is the point of the analogy: CA$47.3bn (~US$34.6bn) against Berkshire's US$1.06trn, i.e. "zipping back time 30 years."
Watch for

4. Read a limit price as a statement of intent, and set yours deliberately

The repeatable method
  1. Decide before placing an order which you are optimising for: certainty of execution, or price.
  2. A limit above the market buys certainty and admits you do not think the price matters at this level. A limit below it demands a discount and accepts non-execution.
  3. Check liquidity before deciding — a small order in a liquid name makes the question moot, and pretending otherwise is theatre.
  4. Publish or record which you chose and why, so the decision can be reviewed against the fill.
Here: CAD 2,300 against a quoted CA$2,272 — 1.2% above the market, on a stock with CA$122m average daily volume against a CAD 69,000 order. Contrast the June transaction issue, where V, KNSL and AMP were all bid below the market. The change of stance is not commented on, but it says the price is not the constraint here.
Watch for

5. Hold new purchases to the same standard of proof as existing holdings

The repeatable method
  1. Write down the evidence you require before opening a position — for this archive that is a fair value, a forward multiple against the company's own history, and a reverse DCF.
  2. When a purchase is announced with less than that, note the gap rather than filling it in yourself.
  3. Ask what is doing the work instead. Here: a track record, an analogy and management's own forecast — all three of which are weaker evidence than a valuation.
  4. Decide whether the substitution is justified by the type of business (holding companies genuinely resist earnings multiples) or whether the standard simply slipped.
  5. Record the omission so the position can be reviewed against it later.
Here: two weeks after publishing a fair value, a forward PE against a five-year average, a reverse DCF and a three-year expected return for all nineteen holdings, this purchase carries none of them. No price-to-book — the standard measure for an insurance holding company — and no expected return. The growth case is one sentence: "Via Fairfax, you get exposure to India which should allow Fairfax to double its intrinsic value every 5 years," alongside "management thinks they can grow by 15% per year."
Watch for

Methods distilled from the archived Compounding Quality post for personal study. Not investment advice.